{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:52:57Z","timestamp":1783612377731,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T00:00:00Z","timestamp":1419811200000},"content-version":"vor","delay-in-days":1854,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1111\/j.1469-0691.2009.02718.x","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T10:41:16Z","timestamp":1258022476000},"page":"1103-1110","source":"Crossref","is-referenced-by-count":5,"title":["Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A \u03b2-haemolytic streptococcal pharyngitis\/tonsillitis in adults and adolescents: a double-blind, double-dummy study"],"prefix":"10.1016","volume":"15","author":[{"given":"D.M.","family":"Jorgensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2009.02718.x_bib1","series-title":"Principles and practice of infectious diseases","first-page":"656","article-title":"Pharyngitis","author":"Gwaltney","year":"2000"},{"issue":"suppl C","key":"10.1111\/j.1469-0691.2009.02718.x_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/37.suppl_C.83","article-title":"An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections","volume":"37","author":"M\u00fcller","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"suppl E","key":"10.1111\/j.1469-0691.2009.02718.x_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/31.suppl_E.137","article-title":"Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections","volume":"31","author":"M\u00fcller","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"suppl C","key":"10.1111\/j.1469-0691.2009.02718.x_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/37.suppl_C.71","article-title":"An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections","volume":"37","author":"O\u2019Doherty","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib5","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1086\/430307","article-title":"Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis","volume":"40","author":"Casey","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib6","first-page":"551","article-title":"Clinical applications of azithromycin microspheres in respiratory tract infections","volume":"2","author":"Blasi","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib7","series-title":"Expanding indications of the new macrolides, azalides and streptogramins","first-page":"22","article-title":"Postantibiotic effects and the dosing of macrolides, azalides and streptogramins","author":"Craig","year":"1997"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/dki241","article-title":"Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models","volume":"56","author":"Girard","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib9","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.49.10.4035-4041.2005","article-title":"Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired pneumonia in adults","volume":"49","author":"D\u2019Ignazio","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib10","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1378\/chest.128.4.2230","article-title":"Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults","volume":"128","author":"Drehobl","year":"2005","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.idc.0000161504.41501.e7","article-title":"Novel, single-dose microsphere formulation of azithromycin versus levofloxacin for the treatment of acute exacerbation of chronic bronchitis","volume":"13","author":"Zervos","year":"2005","journal-title":"Infect Dis Clin Pract"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.otohns.2005.04.020","article-title":"Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults","volume":"133","author":"Murray","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/00006454-199707000-00011","article-title":"Empiric antibiotic selection criteria for respiratory infections in pediatric practice","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/340949","article-title":"Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America","volume":"35","author":"Bisno","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib15","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1542\/peds.108.5.1180","article-title":"Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis","volume":"108","author":"Kaplan","year":"2001","journal-title":"Pediatrics"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/392496","article-title":"Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults","volume":"38","author":"Casey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib17","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.clinthera.2005.08.003","article-title":"A pooled comparison of cefdinir and penicillin in the treatment of group A beta-hemolytic streptococcal pharyngotonsillitis","volume":"27","author":"Brook","year":"2005","journal-title":"Clin Ther"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1185\/030079903125002027","article-title":"Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis\/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients","volume":"19","author":"Takker","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jac\/49.2.337","article-title":"Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study","volume":"49","author":"Portier","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib20","first-page":"956","article-title":"Guidelines for the use of antibiotics in acute upper respiratory tract infections","volume":"74","author":"Wong","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/00006454-199912000-00008","article-title":"Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997","volume":"18","author":"Kaplan","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa013169","article-title":"Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh","volume":"346","author":"Martin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland","volume":"337","author":"Sepp\u00e4l\u00e4","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/501460","article-title":"Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes","volume":"42","author":"Gagliotti","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib25","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/AAC.48.9.3559-3562.2004","article-title":"Emergence of macrolideresistant Streptococcus pyogenes strains in French children","volume":"48","author":"Bingen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0140-6736(92)90339-5","article-title":"Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s","volume":"339","author":"Cleary","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11096-004-6607-0","article-title":"Utilization of macrolides and the development of Streptococcus pyogenes resistance to erythromycin","volume":"27","author":"Urb\u00e1nek","year":"2005","journal-title":"Pharm World Sci"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib28","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(02)09994-4","article-title":"Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial","volume":"360","author":"Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib29","article-title":"Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial","author":"Agarwal","year":"2004","journal-title":"BMJ"},{"key":"10.1111\/j.1469-0691.2009.02718.x_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dkf046","article-title":"Patient compliance with antibiotic treatment for respiratory tract infections","volume":"49","author":"Kardas","year":"2002","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14648539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14648539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:06:46Z","timestamp":1558642006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14648539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1198743X14648539"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02718.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}